Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

A triple threat to diagnostic safety in CTPA: Diagnostic uncertainty, sspe, and reporting discrepancies

Abdulrahman Al Raizah, Aimn W Abdujawad, Mohammed Snnallah, Usman Maitla, Naveed Qureshi, Ahmad Hazzazi, Thuraya Moafa, Khalid Mohamed, Mohsen Al Zahrani, Ayman Hejazi, Ahmed Alaskar

Blood (2025) 146 (Supplement 1): 2605.

https://doi.org/10.1182/blood-2025-2605

Published: 2025

Journal Articles

Overcoming surveillance gaps: Deep learning for accurate detection and chronicity classification of hospital-acquired pulmonary embolism

Abdulrahman Al Raizah, Aimn W Abdujawad, Mohammed Snnallah, Usman Maitla, Naveed Qureshi, Ahmad Hazzazi, Thuraya Moafa, Khalid Mohamed, Mohsen Al Zahrani, Ayman Hejazi, Saad Alotaibi, Ahmed Alaskar, Mshabab Alrizah

Blood (2025) 146 (Supplement 1): 2613.

https://doi.org/10.1182/blood-2025-2613

Published: 2025

Journal Articles

A quality improvement project to optimize VTE prophylaxis in surgical patients

Aimn W Abdujawad, Abdulrahman Al Raizah, Abdullah S. Al Saleh, Mohsen Al Zahrani, Ayman Hejazi, Saad Alotaibi, Mufareh edhah Alkatheri, Ahmed Alaskar

Blood (2025) 146 (Supplement 1): 2617.

https://doi.org/10.1182/blood-2025-2617

Published: 2025

Journal Articles

Secondary malignancies after hematopoietic cell transplantation for sickle cell disease: A single-center experience

Blood (2025) 146 (Supplement 1): 6037.

https://doi.org/10.1182/blood-2025-6037

Published: 2025

Journal Articles

A quality improvement project to optimize IVC filter use and retrieval: Translating guidelines into practice

Blood (2025) 146 (Supplement 1): 1070.

https://doi.org/10.1182/blood-2025-1070

Published: 2025

Journal Articles

Development and validation of a new model for predicting occult cancer after unprovoked VTE and its comparative performance against riete and some scores

Abdulrahman Al Raizah, Nahla Wahby, Khalid Mohamed, Mohammed Snnallah, Mohsen Al Zahrani, Ayman Hejazi, Ahmed Alaskar

Blood (2025) 146 (Supplement 1): 4896.

https://doi.org/10.1182/blood-2025-4896

Published: 2025

Journal Articles

Letermovir cytomegalovirus prophylaxis in hematopoietic-cell transplantation; Real world evidence from high endemic regions.

Rahaf Salem, Lama Alhmaly, Bader Alahmari, Ahmed Alaskar, Husam AlSadi, Ayman Almozaini, Ayman Hejazi, Abdullah S. Al Saleh, Khalid AlHarbi, Mashael AlMutairi, Mazin Ahmed, Nourah Alshuraym, MAYBELLE BALILI, Mohsen Alzahrani

Blood (2025) 146 (Supplement 1): 4277.

https://doi.org/10.1182/blood-2025-4277

Published: 2025

Journal Articles

The fertility outcome in a cohort of SCD patients undergoing haploidentical allogeneic stem cell transplant using NMA regimen.

Blood (2025) 146 (Supplement 1): 2485.

https://doi.org/10.1182/blood-2025-2485

Published: 2025

Journal Articles

Comparison of Interobserver Agreement between the 4T and the HIT Expert Probability (HEP) Scores: We Agreed Not to Agree

Abdulrahman Al Raizah, Rawan Almohamdy, Khalid Alharbi, Albarra Madkhali, Rahaf ElHussein Salem, Mohammed Alshuaibi, Abdullah S. Al Saleh, Mohsen Alzahrani, Ayman Hejazi, Hind Salama, Ahmed Alaskar

Blood (2023) 142 (Supplement 1): 5430.

https://doi.org/10.1182/blood-2023-181649

Published: 2023

Journal Articles

Favorable Fertility Outcome in a Large Cohort of Sickle Cell Disease Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2023) 142 (Supplement 1): 240.

https://doi.org/10.1182/blood-2023-178128

Published: 2023

Journal Articles

Effect of ABO Mismatch and RBC Alloimmunization on the Outcomes of Patients with Sickle Cell Disease Undergoing Hematopoietic Stem Cell Transplantation

Blood (2022) 140 (Supplement 1): 7599–7600.

https://doi.org/10.1182/blood-2022-158787

Published: 2022

Journal Articles

Favourable Outcome of Non Myeloablative Allogeneic HSCT in Adult Patients with Severe Sickle Cell Disease: A Single Center Experience of 110 Patients

Mohsen Alzahrani, Bader Alahmari, Ahmed Alaskar, MD FRCPC, Ayman Hejazi, Giamal Edin Gmati, MD, Khadega A. Abuelgasim, Hind Salama, Abdulrahman Raiza, Abdulrahman Alghamdi, Walid Mashaqbeh, Heba Alshobaki, Tahani Alanazy, Maybelle Balili, Muhammad Qureshi, Mazin Ahmed, Husam Mazin Alsadi, MD, Moussab Damlaj

Blood (2020) 136 (Supplement 1): 1–2.

https://doi.org/10.1182/blood-2020-139348

Published: 2020

Journal Articles

Home Care Program for Managing Oncology Patients during COVID-19 Pandemic. a Tertiary Referral Center Experience

Giamal Edin Gmati, MD, Nadine Mabsut, Zainab Matar, Mona Alshami, Husam Shahata, Areej Alkhesaifi, Mohamed Alharbi, Nashmia Almutairi, Ashwaq Alolayan, Mohsen Alzahrani, Abdullah Algarni, Abdulrahman Alhadab, Ayman Hejazi, Bader Alahmari, Abdul-Rahman Jazieh, MD

Blood (2020) 136 (Supplement 1): 21.

https://doi.org/10.1182/blood-2020-141782

Published: 2020

Journal Articles

Prevalence of Gaucher Disease in Patients of Unknown Cause of Splenomegaly and/or Thrombocytopenia in Saudi Arabia

Marwan Elbagoury, MSc, Abdulelah Ismail Qadi, Ayman Hejazi, Fahad Alabbas, Ghaleb El Yamany, MBBS, FRCP, FRCPath, Hussain H. Al Saeed, MBBS, MD, Ohoud F. Kashari, MBBS

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-140563

Published: 2020

Journal Articles

Outcome of Age-Adapted Approach to HLA-Identical Related Hematopoietic Stem Cell Transplantation in Severe Sickle Cell Disease: Saudi Experience

Mohsen Alzahrani, Moussab Damlaj, Mohammed Essa, Bader Alahmari, Ahmed Alaskar, Ayman Hejazi, Enas Basher, Rodaina Abujoub, Samer Ghazi, Khadega Abuelgasim, Hind Salama, Giamal Gmati, Abdulrahman Alsultan

Blood (2018) 132 (Supplement 1): 3468.

https://doi.org/10.1182/blood-2018-99-115800

Published: 2018

Journal Articles

Non-Myeloablative Transplant in Severe Sickle Cell Disease Is Safe & Effective. Single Center Experience from Saudi Arabia

Mohsen Al-Zahrani, MD, Ahmed Alaskar, MD FRCPC, Moussab Damlaj, MD, Khadega Abuelgasim, MD, Giamal Gmati, MD, Hind ABDIN Salama, MD, Samer Ghazi, Osama Ali, MD, Bader Alahmari, MD, Ayman Hejazi, MD

Blood (2017) 130 (Supplement 1): 5549.

https://doi.org/10.1182/blood.V130.Suppl_1.5549.5549

Published: 2017

Journal Articles

Prognostic Impact of Blood Count Recovery Based Complete Remission Prior to Allogeneic Transplantation in Patients with Acute Leukemia

Moussab Damlaj, MD, Ghazi Samer, Giamal Edin Mohamed Gmati, MD, Walid Mashaqbeh, Mohsen Al Zahrani, MD, Khadega Ahmed Abuelgasim, MD, Mushtaq Rather, MD, Hend Salama, MD, Ahmed Askar, MD, Ayman Hejazi, MD

Blood (2016) 128 (22): 5787.

https://doi.org/10.1182/blood.V128.22.5787.5787

Published: 2016

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

A triple threat to diagnostic safety in CTPA: Diagnostic uncertainty, sspe, and reporting discrepancies

Overcoming surveillance gaps: Deep learning for accurate detection and chronicity classification of hospital-acquired pulmonary embolism

A quality improvement project to optimize VTE prophylaxis in surgical patients

Secondary malignancies after hematopoietic cell transplantation for sickle cell disease: A single-center experience

A quality improvement project to optimize IVC filter use and retrieval: Translating guidelines into practice

Development and validation of a new model for predicting occult cancer after unprovoked VTE and its comparative performance against riete and some scores

Letermovir cytomegalovirus prophylaxis in hematopoietic-cell transplantation; Real world evidence from high endemic regions.

The fertility outcome in a cohort of SCD patients undergoing haploidentical allogeneic stem cell transplant using NMA regimen.

Comparison of Interobserver Agreement between the 4T and the HIT Expert Probability (HEP) Scores: We Agreed Not to Agree

Favorable Fertility Outcome in a Large Cohort of Sickle Cell Disease Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Effect of ABO Mismatch and RBC Alloimmunization on the Outcomes of Patients with Sickle Cell Disease Undergoing Hematopoietic Stem Cell Transplantation

Favourable Outcome of Non Myeloablative Allogeneic HSCT in Adult Patients with Severe Sickle Cell Disease: A Single Center Experience of 110 Patients

Home Care Program for Managing Oncology Patients during COVID-19 Pandemic. a Tertiary Referral Center Experience

Prevalence of Gaucher Disease in Patients of Unknown Cause of Splenomegaly and/or Thrombocytopenia in Saudi Arabia

Outcome of Age-Adapted Approach to HLA-Identical Related Hematopoietic Stem Cell Transplantation in Severe Sickle Cell Disease: Saudi Experience

Non-Myeloablative Transplant in Severe Sickle Cell Disease Is Safe & Effective. Single Center Experience from Saudi Arabia

Prognostic Impact of Blood Count Recovery Based Complete Remission Prior to Allogeneic Transplantation in Patients with Acute Leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only